Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab

Sukhpal Singh Sandhu1,2, Sridhar Manvikar1, David Henry William Steel11Sunderland Eye Infirmary, Sunderland, United Kingdom; 2Centre for Eye Research Australia, Melbourne, AustraliaBackground/aims: To evaluate retrospectively the clinical outcomes of patients presenting with submacular hemorrhage (S...

Full description

Bibliographic Details
Main Authors: Sukhpal Singh Sandhu, Sridhar Manvikar, David Henry William Steel
Format: Article
Language:English
Published: Dove Medical Press 2010-06-01
Series:Clinical Ophthalmology
Online Access:http://www.dovepress.com/displacement-of-submacular-hemorrhage-associated-with-age-related-macu-a4634
_version_ 1819005861545115648
author Sukhpal Singh Sandhu
Sridhar Manvikar
David Henry William Steel
author_facet Sukhpal Singh Sandhu
Sridhar Manvikar
David Henry William Steel
author_sort Sukhpal Singh Sandhu
collection DOAJ
description Sukhpal Singh Sandhu1,2, Sridhar Manvikar1, David Henry William Steel11Sunderland Eye Infirmary, Sunderland, United Kingdom; 2Centre for Eye Research Australia, Melbourne, AustraliaBackground/aims: To evaluate retrospectively the clinical outcomes of patients presenting with submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD), treated by vitrectomy, submacular tissue plasminogen activator (tPA) injection and pneumatic displacement of SMH with air followed by postoperative intravitreal ranibizumab (RZB).Methods: Patients with SMH and nAMD had 25-guage vitrectomy and subretinal tPA (12.5 micrograms/0.1 mL) with fluid/air exchange. Intravitreal RZB was administered postoperatively to patients eligible for National Health Service (NHS) funded treatment.Results: Of the total of 16 patients, 11 (68.7%) had complete displacement of SMH. The remaining five had residual SMH, mainly subretinal pigment epithelium in location. Three of the four patients who previously had a failed expansile gas pneumatic displacement were successfully displaced with vitrectomy surgery. At presentation 5/16 (31.3%) patients were eligible for NHS funded intravitreal RZB. This increased to 12 patients after the vitrectomy procedure (75.0%). At 6 months postoperatively all improved by $1 line. Ten of the 16 patients (63%) improved by ≥2 lines, with 10 of the 12 patients (83%) treated with RZB improving by ≥2 lines.Conclusion: Vitrectomy/subretinal tPA/air to displace SMH followed by intravitreal RZB injection can stabilize/improve vision in patients with nAMD. This technique displaces hemorrhage not displaced by attempted expansile gas techniques.Keywords: submacular hemorrhage, neovascular age-related macular degeneration, vitrectomy, tissue plasminogen activator, ranibizumab
first_indexed 2024-12-20T23:59:31Z
format Article
id doaj.art-b9af66fadac34d249eed5524dbc28ff3
institution Directory Open Access Journal
issn 1177-5467
1177-5483
language English
last_indexed 2024-12-20T23:59:31Z
publishDate 2010-06-01
publisher Dove Medical Press
record_format Article
series Clinical Ophthalmology
spelling doaj.art-b9af66fadac34d249eed5524dbc28ff32022-12-21T19:22:40ZengDove Medical PressClinical Ophthalmology1177-54671177-54832010-06-012010default637642Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumabSukhpal Singh SandhuSridhar ManvikarDavid Henry William SteelSukhpal Singh Sandhu1,2, Sridhar Manvikar1, David Henry William Steel11Sunderland Eye Infirmary, Sunderland, United Kingdom; 2Centre for Eye Research Australia, Melbourne, AustraliaBackground/aims: To evaluate retrospectively the clinical outcomes of patients presenting with submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD), treated by vitrectomy, submacular tissue plasminogen activator (tPA) injection and pneumatic displacement of SMH with air followed by postoperative intravitreal ranibizumab (RZB).Methods: Patients with SMH and nAMD had 25-guage vitrectomy and subretinal tPA (12.5 micrograms/0.1 mL) with fluid/air exchange. Intravitreal RZB was administered postoperatively to patients eligible for National Health Service (NHS) funded treatment.Results: Of the total of 16 patients, 11 (68.7%) had complete displacement of SMH. The remaining five had residual SMH, mainly subretinal pigment epithelium in location. Three of the four patients who previously had a failed expansile gas pneumatic displacement were successfully displaced with vitrectomy surgery. At presentation 5/16 (31.3%) patients were eligible for NHS funded intravitreal RZB. This increased to 12 patients after the vitrectomy procedure (75.0%). At 6 months postoperatively all improved by $1 line. Ten of the 16 patients (63%) improved by ≥2 lines, with 10 of the 12 patients (83%) treated with RZB improving by ≥2 lines.Conclusion: Vitrectomy/subretinal tPA/air to displace SMH followed by intravitreal RZB injection can stabilize/improve vision in patients with nAMD. This technique displaces hemorrhage not displaced by attempted expansile gas techniques.Keywords: submacular hemorrhage, neovascular age-related macular degeneration, vitrectomy, tissue plasminogen activator, ranibizumabhttp://www.dovepress.com/displacement-of-submacular-hemorrhage-associated-with-age-related-macu-a4634
spellingShingle Sukhpal Singh Sandhu
Sridhar Manvikar
David Henry William Steel
Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
Clinical Ophthalmology
title Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
title_full Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
title_fullStr Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
title_full_unstemmed Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
title_short Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
title_sort displacement of submacular hemorrhage associated with age related macular degeneration using vitrectomy and submacular tpa injection followed by intravitreal ranibizumab
url http://www.dovepress.com/displacement-of-submacular-hemorrhage-associated-with-age-related-macu-a4634
work_keys_str_mv AT sukhpalsinghsandhu displacementofsubmacularhemorrhageassociatedwithagerelatedmaculardegenerationusingvitrectomyandsubmaculartpainjectionfollowedbyintravitrealranibizumab
AT sridharmanvikar displacementofsubmacularhemorrhageassociatedwithagerelatedmaculardegenerationusingvitrectomyandsubmaculartpainjectionfollowedbyintravitrealranibizumab
AT davidhenrywilliamsteel displacementofsubmacularhemorrhageassociatedwithagerelatedmaculardegenerationusingvitrectomyandsubmaculartpainjectionfollowedbyintravitrealranibizumab